Brandon Allison, Author at Industry Standard Research

Technologies & Capabilities in Demand for Oral Dosage Forms Manufacturing

Outsourced Manufacturing for Oral Dosage Forms From the commonly available tablets and capsules to more specialized forms like bi-layer and chewables, oral dosage forms remain the most popular drug products on the market. In this highly competitive and flourishing landscape,…

Brandon Allison

Gene Therapy Timelines & CDMO Selection Attributes

Manufacturing

Gene Therapy CDMO Timelines & Selection Attributes

The Long Road to Approval for Gene Therapies We’ve come a long way from the first gene therapy clinical trial in 1990, but for all the hurdles overcome and advancements made, timelines remain one of the most prominent pain points…

Brandon Allison

Clinical Trials

Five Steps to CRO Selection

Sponsors can facilitate successful CRO partnerships by clearly defining the goals of the clinical trial, choosing an outsourcing model that considers project needs and internal capabilities/resources appropriately, communicating consistently and effectively during the decision-making process, and informing provider selection with…

Brandon Allison

Manufacturing

Biopharma Outsourcing Trends for Sterile Injectable Manufacturing

Evolving Perceptions and Practices in Sterile Injectable Outsourcing Sterile injectable medicines provide significant advantages in terms of rapid and accurate drug delivery. Many newer medications cannot be produced as an oral dosage form for various reasons, making injectable delivery an…

Brandon Allison

Manufacturing

Cell & Gene Therapies Outsourcing Trends

The Growing Cell & Gene Market The outsourced cell and gene manufacturing space has experienced notable expansion and change in recent years. As the advancement of cell and gene therapies continues, drug innovator companies have come to rely heavily on…

Brandon Allison

Articles

Sponsor Perspectives on Outsourced Clinical Trial Logistics

ISR consistently seeks to demystify the mystical, and there’s plenty of mystery regarding clinical trial logistics. How do sponsors select a provider? Which activities do they outsource the most? Where are these questions heading? To none other than ISR’s latest…

Brandon Allison

Articles

Highly Potent API Manufacturing

Highly potent API manufacturing is a rapidly growing segment of drug development. Those familiar with HPAPI understand its specialized nature and the strict regulations surrounding it. A complicated and resource-intensive process, sponsors often find themselves in need of knowledgeable outsourcing…

Brandon Allison

Articles

Commercial Bioprocessing Market Outlook

Choosing an outsourcing partner for a commercial bioprocessing endeavor carries a gravitas that those outside that endeavor may not appreciate. Equally significant is the challenge facing CMOs in this space, many of whom are competing against larger, well-known manufacturers with…

Brandon Allison

Articles

Cell & Gene Market Outlook

I bet you can’t say “cell & gene therapies” three times fast. And by the time you do, you’ll have missed another article on your newsfeed discussing their intricacies and the headaches they can cause. Here’s one from Industry Standard…

Brandon Allison

Articles

CTMS Benchmarking & Market Dynamics

ISR’s CTMS Benchmarking & Market Dynamics (3rd Ed.) aims to tackle clinical trial management systems (CTMS) by helping providers and sponsors alike better understand current trends surrounding this technology and anticipate future ones. This report is the result of primary…

Brandon Allison